Clear The Air News Tobacco Blog Rotating Header Image

Europe

Tobacco lobbyists demand say in EU debate on … tobacco lobbying

http://www.politico.eu/article/tobacco-lobbyists-demand-say-in-eu-debate-on-tobacco-lobbying-european-parliament-european-ombudsman-emily-oreilly/

When European Ombudsman Emily O’Reilly announced she would host a public conference on how to improve transparency in tobacco lobbying, her office quickly found itself grappling with an ethical predicament: Should tobacco lobbyists be let in?

It may sound counter-intuitive to prevent the industry that this Wednesday’s conference will discuss from having an official role in it. Yet the organizers of a similar event in the European Parliament earlier this month did just that, arguing that they were required to keep tobacco lobbyists out by an international treaty.

In the past, the ombudsman has expressed concerns about the lack of transparency surrounding tobacco lobbying, causing some anti-tobacco campaigners to expect a strong statement from her which would set a standard for other EU institutions. But tobacco lobbyists were equally worried that they would be shut out altogether from a debate directly involving them.

“What could be more transparent than a public debate?” — Tobacco lobbyist

The issue is how the EU chooses to implement the Framework Convention on Tobacco Control (FCTC), a United Nations deal signed by EU institutions that seeks to keep the tobacco industry out of the health policy process. The language in the treaty is open to interpretation, but lobbyists insist it should not be used to ban them from public events.

“Keeping the industry off the panel while they talk about our business doesn’t make any sense and has nothing to do with FCTC,” one tobacco lobbyist said. “For an event supposedly about transparency, what could be more transparent than a public debate?”

The ombudsman ultimately chose a compromise likely to please nobody: Tobacco lobbyists can attend as audience members, but will not be invited to join the panel discussion. Anti-tobacco and transparency campaigners will be unhappy about policymakers and lobbyists sharing a venue; lobbyists argue they are being denied their right to free expression.

In any case, the upshot is that when European Commissioner for Health Vytenis Andriukaitis arrives at the event in Brussels, he will be surrounded by tobacco lobbyists — although not all of them will be immediately recognizable as such.

According to a preliminary list of participants, some lobbyists who plan to attend have not signed up to the EU Transparency Register and, therefore, should be barred from having any interaction with the commissioner and his staff.

The controversy is forcing EU health bureaucrats to figure out how to implement provisions regarding industry lobbyists, and to decide whether a hard-line stance will expose them to the accusation they are stifling debate on the future of a legal product.

No blanket ban

The dispute focuses on an article in the convention which states that when “setting and implementing” public health policies, officials should “protect these policies from commercial … interests of the tobacco industry.”

The industry argues that the ombudsman’s conference, which has nothing to do with formulating health policy, does not fall under the remit of the article. What’s more, it says the thrust of the convention is to bring about transparency in tobacco lobbying — something most industry representatives accept.

This argument gets some unlikely support from the framework convention itself: Officials at the FCTC Secretariat point to the accompanying guidelines as the key to understanding how governments should handle day-to-day interaction with lobbyists.

“The Convention calls [on] parties to limit their interactions with the tobacco companies and their interests as much as possible, but does not mandate a blanket ban,” said Tibor Szilágyi at the secretariat in Geneva. “However, the [FCTC] calls for transparency of interactions that still occur.”

The largest tobacco industry association, the Confederation of European Community Cigarette Manufacturers, is relieved to be let in but is still angry at being excluded from a panel including Giovanni La Via, who chairs the European Parliament’s public health, food safety and environment committee.

The group wrote to O’Reilly on April 19 to protest, according to a redacted version of the correspondence released by the ombudsman’s office. An uncensored version of the letter, seen by POLITICO, was signed by Ronan Barry, a British American Tobacco executive and president of the industry body.

Tobacco manufacturers were “disappointed” by O’Reilly’s decision not to invite them, Barry said, urging her to “reconsider our request to allow a representative [to] participate fully in the event as a speaker” or at least to ensure that the industry be “provided with adequate time to present our position and address any queries” raised in the debate.

The response from ombudsman spokesperson Gundi Gadesmann made it clear officials were taking a strict interpretation of the tobacco control treaty, meaning they could not involve the industry in the official discussion.
“It would be harmful if they started taking the floor all the time and hijacked the discussion” — Florence Berteletti, director of Smoke-Free Partnership, an anti-tobacco NGO

In line with the convention, they did not invite in industry representative, she wrote, adding that the event “is not about the tobacco industry. It is about how the EU institutions comply with their transparency obligations as regards their dealings with representatives from the industry.”

That left the tobacco industry fuming. One tobacco lobbyist said the letter proves how indefensible the ombudsman’s position is, because it conceded the conference was not about the formulation or implementation of health policy.

Yet Article 5.3 of the tobacco convention, which Gadesmann invoked in her justification to exclude industry panelists, refers specifically to the “setting and implementing” of public health policies.

Hijack

Industry sources said Barry planned to try to speak from the audience to confront the ombudsman about her decision to exclude tobacco manufacturers from the panel.

“It would be harmful if they started taking the floor all the time and hijacked the discussion,” said Florence Berteletti, director of Smoke-Free Partnership, an anti-tobacco NGO. “I would hope they would intervene just once and that the discussion would then move on.”

Tobacco lobbyists are dismayed but not surprised. In February, O’Reilly took aim at the European Commission for not making its dealings with the tobacco industry “more transparent” and for lacking “proactivity” in implementing the convention

However, the ombudsman’s decision to let lobbyists attend the conference gives the industry an opportunity to make its presence felt. The preliminary list of attendees, obtained by POLITICO, suggests at least 17 industry representatives have already signed up.

The list highlights the challenge of enforcing the requirement that signatories to the convention “ensure that all operations and activities of the tobacco industry are transparent.” Under EU transparency rules, it’s possible for some lobbyists to avoid disclosing their activities.

For example, Brussels lawyer Kathryn Davies, from the firm Berwin Leighton Paisner, will be in the audience, according to the list. When contacted, Davies declined to reveal whether her firm was working for tobacco companies.

Lawyers are not required to sign up to the European Parliament and Commission Joint Transparency Register, even if they are working as lobbyists. As a result, the names of their clients often remain secret, protected by attorney-client confidentiality.

Some lobbyists who will be in the audience are also not signed up to the Register, which means that under EU rules they will not be allowed to interact in any way with Andriukaitis or members of his cabinet.

Lobbyist Finn Meunier, who works for German firm Concilius AG, would not disclose whether he would attend on behalf of a tobacco company. Another German lobby firm called 365 Sherpas did not respond to requests for information.

Among the lobbyists who are listed on the Register and will therefore be able to speak to the commissioner and his staff are those from Bernstein Public Policy and Red Flag, representing British American Tobacco; lobby firm Pantarhei Advisors Europe, for Philip Morris; and Kreab, representing Swedish Match. Imperial Tobacco and British American Tobacco will also be represented by in-house lobbyists.

Quentin Ariès contributed reporting to this article.

Authors:
James Panichi

Pressure grows for Commission President Juncker to end tobacco lobbying secrecy

Splits occur within European Commission, as European Parliament, Ombudsman and NGOs increase the pressure for implementing UN rules for contacts with tobacco industry lobbyists.

http://www.corporateeurope.org/power-lobbies/2016/04/pressure-grows-commission-president-juncker-end-tobacco-lobbying-secrecy

In February, European Commission President Juncker took many by surprise by flatly rejecting a European Ombudsman’s ruling recommending full transparency around tobacco industry lobbying. The previous autumn (after an investigation sparked by a complaint by Corporate Europe Observatory), Ombudsman Emily O’Reilly had slammed the Commission’s failure to comply with the World Health Organisation’s Framework Convention on Tobacco Control as ‘maladministration’. The ruling urged the Commission to publish details of all meetings with tobacco lobbyists online. Four months later Juncker responded by claiming that the Commission “complies in full” with the UN rules, repeating the unconvincing argument that its general rules in the field of transparency and ethics are sufficient.

In her speech “Combating tobacco industry tactics: State of play and a way forward” in the European Parliament a few weeks later, O’Reilly expressed strong regret “that the Commission declined to accept my recommendation to extend proactive tobacco lobbying transparency across all DGs and across all levels of the service.” “And, given the stated commitment of the EU to the Convention”, the Ombudsman added, “I confess to being puzzled as to why that is.” In the conclusions of her speech, O’Reilly offered at least a partial explanation, stating that “the sophistication of the tobacco industry’s global lobbying efforts is still seriously underestimated”.

The Ombudsman, fortunately, has far from given up. Within a few weeks, she will publish a final ruling on the case. O’Reilly is also organising an official hearing in the European Parliament on “Improving transparency in tobacco lobbying”. Among the speakers will be Vytenis Andriukaitis, European Commissioner for Health. Andriukaitis has recently voiced strong disagreement with Juncker’s rejection of the Ombudsman’s recommendations. Last month, Andriukaitis revealed at a conference in the European Parliament that Juncker’s response to the Ombudsman had not been discussed in the College for Commissioners. He reported that it was drafted by the Commission’s Legal Services, signed by Juncker and sent to the Ombudsman without consulting other commissioners.

In a resolution approved in a plenary vote last month, the European Parliament added to the pressure on the Commission, stating its concerns about the Ombudsman’s finding that the Commission was “not fully implementing UN WHO rules and guidelines governing transparency and tobacco lobbying”, adding that the Parliament “is of the opinion […] that the Commission’s credibility and seriousness have been endangered”. The Parliament’s resolution “urges all the relevant EU institutions to implement Article 5(3) of the WHO Framework Convention on Tobacco Control (FCTC) in accordance with the recommendations contained in the guidelines thereto”.

In his response to the Ombudsman, Juncker argued that tobacco lobbying transparency is not needed because the number of meetings between top officials and tobacco lobbyists has decreased since decision-making on the Tobacco Products Directive came to an end in 2014. This is a clear example of the European Commission seriously underestimating the lobbying efforts of the tobacco industry. Tobacco lobbyists are now targeting other issues, such as EU trade policy (TTIP and other trade negotiations), the renewal of the controversial agreements with four tobacco giants on combating illicit trade in tobacco, and the battle around the choice of technology for high-tech digital watermarks in tobacco packaging to prevent counterfeiting. New documents uncovered by CEO – see box below – show the tobacco industry is also making full use of the Commission’s flagship “Better Regulation” initiative in attempts to weaken tobacco control measures such as health warnings on cigarette packs. This has included attempts to bypass the health commissioner by lobbying the cabinet of Commission Vice-President Timmermans, who is responsible for ’Better Regulation’.

The European Parliament, the health commissioner and public health NGOs are calling on the Commission to accept the Ombudsman’s recommendations. So what is Juncker waiting for?

Tobacco industry lobbyists using the Commission’s “Better Regulation” agenda

After attending a BusinessEurope meeting with the Commission on the Commission’s “Better Regulation” package, Japan International Tobacco (JTI) requested a meeting with the cabinet of Commission Vice-President Timmermans to “discuss a number of specific areas”. When the meeting happened (November 25 2015), the JTI lobbyists only raised “a very specific issue” concerning “the placing of health warning on cigarette packs with bevelled sides”. JTI attempted to use the “Better Regulation” agenda in its lobbying on this issue and went to Timmermans’ cabinet to bypass the Commission’s health department. The cabinet member promised to contact the cabinet of the health commissioner “to hear their side of the story”, but the notes of the meeting also stress that “no further commitments were undertaken”. This meeting was disclosed because it involved a top Commission official, but how many more meetings like this are happening at lower levels?

‘No’ to deals with tobacco firms

http://www.europarltv.europa.eu/en/player.aspx?pid=759f7750-600e-45a3-a9c0-a5bf00dfca63

MEPs urge the Commission not to extend an anti-smuggling and anti-counterfeiting deal with Philip Morris International (PMI), saying the focus should instead be on using legislative tools.

This motion has passed clearly.

What we need is track and trace and due diligence, first of all in raw cut tobacco. If we do something at the start of the production chain rather than at the end, we will quickly come to a result. Today, the growing problem of cheap whites requires us to continue to work with our Member States to tackle it. Madame Commissioner, let’s not pretend that the tobacco industry is our friend. It’s an opponent instituting legal proceedings against the tobacco directive. The inquirers had to conclude, and that’s very important, that the cooperation with PMI has not demonstrably benefited public health.

Extending the deal with Philip Morris is like trusting the fight against organised crime to Al Capone.

Cigarettes: MEPs oppose renewing EU anti-smuggling deals with tobacco firms

http://www.europarl.europa.eu/news/en/news-room/20160303IPR16929/Cigarettes-MEPs-oppose-renewing-EU-anti-smuggling-deals-with-tobacco-firms

A majority of MEPs urged the European Commission not to renew an EU anti-smuggling and anti-counterfeiting deal with Philip Morris International (PMI), which expires in July 2016, in a resolution voted on Wednesday. Instead, they ask it to focus on using EU and international legislative tools to combat smuggling.

MEPs note that the PMI deal proved ineffective because although it initially reduced smuggling, a surge in smuggled non-branded “cheap white” cigarettes soon filled the gap.

Under the tobacco deals the four largest tobacco firms together agreed to pay the EU and its member states a total of $2.15 billion, over the lifetime of the agreements, to drop legal proceedings against them to recover duties lost to illegal trade in cigarettes. Companies also agreed actively to combat smuggling and counterfeiting of tobacco products.

MEPs note that illicit trade in tobacco products, and in particular the smuggling of contraband and counterfeit cigarettes, still deprives the EU and its member states of revenue (customs, VAT and excise duties) amounting to more than €10 billion a year.

MEPs also worry that annual payments from the tobacco industry to help fund the European Anti-Fraud Office (OLAF) budget, as mentioned in the tobacco agreements, could lead to a conflict of interest.

Rather than renew the PMI deal, MEPs urge the Commission to focus on implementing the 2014 EU Tobacco Directive, which provides for more effective tools, such as an interoperable tracing and tracking system for the cigarettes at EU level, to take effect in 2019. Member states should also ratify a protocol to the WHO Framework Convention on Tobacco Control (FCTC), which does the same internationally..

MEPs stress that WHO Protocol parties are obliged to protect their public health policies from tobacco industry commercial interests and that no obligation assigned to a party should be delegated to this industry.

To bridge the time gap until all provisions of the Tobacco Products Directive become fully enforceable, MEPs ask the Commission to prepare additional new rules dealing with “cheap white” cigarettes, to track and trace PMI tobacco products and to bring legal action against any illegal seizures of the latter.

We’re unsure if e-cigarettes are harmful, but it still makes sense to restrict them

https://theconversation.com/were-unsure-if-e-cigarettes-are-harmful-but-it-still-makes-sense-to-restrict-them-55777

E-cigarettes have rapidly risen in popularity in recent years and are now the subject of heated debate as to whether they are effective in helping smokers quit tobacco or whether they are actually making smoking attractive to young people. Are they a way for Big Tobacco to protect its profits in markets where smoking is declining and lure people back into nicotine addiction or are they just a fashion that will quickly lose its appeal?

Given that vaping has been around for barely a decade and studies into the long-term effects take time, we cannot answer these questions with certainty yet. The benefits of e-cigarettes’ continue to be debated – and the potential risks to non-smokers and young people remain under-explored.

This makes it difficult to make recommendations, but politicians across the world are nonetheless having to decide what to do. The latest country to confront this question is Scotland, where the parliament has just voted to ban under-18s from using e-cigarettes. One of a raft of restrictions, this imposes the same age limit as for traditional cigarettes, bringing Scotland broadly into line with England and Wales. Was it the right thing to do?

Different countries have taken different approaches to vaping. Canada has technically made sales illegal, though regulation remains largely unenforced. While regulation across the US is mixed, San Francisco has just raised the minimum buying age from 18 to 21 years.

In some European countries, – among them Bulgaria, Ireland and Poland – sales and advertising are unregulated. In May, however, new EU regulations will impose standardised quality control on liquids and vaporisers across the union as well as requiring disclosure of ingredients in vaping liquids and child-proofing and tamper-proofing for liquid packaging. They will also restrict cross-border advertising. Wales meanwhile looks likely to extend its restrictions by introducing a ban on e-cigarettes in public places.

The ayes and the noes

In the run up to the vote on the new Scottish Health Bill, opponents and supporters of e-cigarette regulations fiercely debated which approach was the most sensible. Opponents usually argue that vaping is less harmful than traditional cigarettes and effective in helping smokers to quit. They want minimal restrictions on availability and complete freedom for advertising, promotion and the use of e-cigarettes in public. Restrictions, they argue, might prevent smokers from switching to safer alternatives and reduce the chances of curbing tobacco consumption.

Supporters of regulation say that children and young people need to be protected from using products which imitate smoking and from developing nicotine addiction. They also favour regulation to ensure product safety and quality. They advocate a precautionary approach until there is evidence that e-cigarettes do not undermine our recent successes at controlling tobacco.

As well as banning sales to under-18s, the new Scottish laws require retailers to ask for proof of age when selling to someone that looks under 25 (similar to alcohol). They ban the sale of e-cigarettes from vending machines, make it an offence to buy on behalf of someone under 18, and require retailers to put their names on a product register. Scottish ministers will also have the power to further restrict or prohibit advertising and promotions in future.

Tighter shackles, please

While the evidence about the risks of e-cigarettes is likely to remain unclear for several years, the Scottish parliament can at least say it is doing what the country wants. A large majority of respondents backed regulation in the consultation of 2014, including representatives of health bodies, local authorities, charities, academics and members of the public. As well as supporting a ban on sales to under-18s or adults buying e-cigarettes on their behalf and preventing young people from seeing advertising and promotions, respondents also widely endorsed restricting the use of e-cigarettes in public places.

‘Save me from myself’ Milles Studio

The Scottish public’s desire for these kinds of rules is also reflected in research I co-published that looked at debates about e-cigarettes in the UK media and found that supporters of regulation greatly outnumbered opponents. I have also been involved in a new study, about to be published, which investigates the views of UK adolescents on regulation. We found they have a very sophisticated understanding of the advantages and disadvantages. While aware of the potential benefits of e-cigarettes to smokers – including those teenage smokers who want to quit – young people overwhelmingly support strong e-cigarette regulation. This includes restrictions on sales to minors, marketing and the use of e-cigarettes in public places.

The reality is that, until the jury returns, it makes sense to trust the public to reach a view from the best information on e-cigarettes that is available. Even if current regulations were to end up looking disproportionate in years to come, no one will be able to accuse the Scottish government of ignoring people’s concerns and taking public health issues lightly. In a situation where no one really knows what to do for the best, regulation which restricts access and promotion to young people looks like the best policy.

Anti-tobacco lobby urges MEPs to reject Philip Morris deal

https://euobserver.com/economic/132539

Politicians and activists fiercely opposed to the tobacco industry are trying to persuade MEPs to speak out against renewing an EU anti-smuggling agreement with multinational Philip Morris International (PMI).

The centre-left socialists, the second-largest parliamentary group, agreed on Wednesday (2 March) to reject any renewal of the deal. The European Parliament is currently preparing a text on the EU-PMI deal to be voted on in Strasbourg next week.

Formally, MEPs have no say on whether or not the European Commission decides to begin new negotiations with PMI to continue the 12-year-old deal, which is set to expire in July.

But although next week’s resolution is non-binding, a strongly worded text with a broad support would be politically difficult for the commission to ignore.

“My message to the European Parliament: please be united,” EU health commissioner Vytenis Andriukaitis told a conference in parliament on Wednesday titled Combating Tobacco Industry Tactics.

Andriukaitis is against renewing the deal.

“I see no reasons for this extension,” he said, adding that he did not agree with those who argue there could be a regulatory gap if no deal is agreed.

‘A very stupid industry’

The EU-PMI agreement, which cemented a partnership between the tobacco firm and the EU’s anti-fraud agency Olaf, obliged PMI to keep track of its products to prevent smuggling. PMI also paid roughly €1 billion into the EU and member state budgets.

But many of the provisions have since been adopted as EU legislation, due to come into force in 2019. Some are now arguing that a bridge deal is required.

The health commissioner argued the tobacco industry had to prepare for that legislation anyway, saying: “I don’t see a regulatory gap.”

He would not say which of his fellow commissioners are arguing in favour of renewing the deal, but a letter from his colleague commissioner Pierre Moscovici, seen by this website, said that the college of commissioners “wants more time to think about it – proof that it is not so settled among my colleagues”.

Andriukaitis reaffirmed that the college would not make a decision before the parliament vote, adding that he expected a decision at the college meeting on 16 March.

The Lithuanian politician has strong views about the tobacco industry, which he called “a very stupid industry”.

“They produce a product which kills their consumers every year,” he said.

“Strange business. It’s a very strange business. Last year they killed 700,000 Europeans. It’s unacceptable.”

He called on tobacco firms to reform their business: “Please, start to change your industry and to produce shoes, for example.”

His audience applauded and cheered his emotional speech. Tobacco lobbyists were not allowed to be present, in line with a World Health Organisation treaty, the Framework Convention on Tobacco Control.

EU credibility at risk

Katharina Kummer Peiry was present on behalf of the secretariat of the convention.

She also argued against negotiating for a renewal.

“There are numerous legal and technical reasons to ditch this agreement, but there is one absolutely critical issue that has an impact worldwide,” Kummer Peiry said.

“Tobacco companies are desperate for respectability. They really can’t allow us to see them for what they are: Multimillion euro businesses enthusiastically peddling a product that kills its consumers.”

She said that tobacco companies are executing a “global rebranding” campaign.

“In this imaginary incarnation, tobacco companies are responsible global citizens working as partners with governments, law enforcement agencies, and others. A renewed EU agreement would assist this campaign,” she said.

Andriukaitis’ predecessor, former Maltese commissioner Tonio Borg, was also on the panel. He warned against the loss of credibility the EU would suffer if it renewed the deal, bringing to memory that PMI had legally challenged the tobacco products directive.

He said: “How can we sign an agreement when we are in court with the other side?

“Why risk the image of the Commission, and of the European Union in general?

“I don’t have proof, but sometimes I have this feeling that this money is not being used explicitly to fight tobacco smuggling, to the extent that the member states want to retain this free money coming in from the tobacco industry.”

Linda McAvan, British MEP of the centre-left socialists, said tobacco companies like PMI want such agreements “to have access to politicians”.

“I think there is a move across parliament now, so I’m hopeful we will get a strong message next week in our resolution, to reject any new agreement,” she said.

A European Parliament source said the left-wing Greens, the far-left GUE/NGL group and the eurosceptic EFDD group were expected to vote against renewal, but this would not yet constitute a majority.

Anti-tobacco group Smoke Free Partnership is distributing a document with counter-arguments among “key MEPs”.

Borg, who was commissioner on behalf of the centre-right EPP, the largest group in the parliament, said he had a “hunch” the group would “follow soon” in taking a common stance on rejecting an extension.

EPP spokesman Pete Pakarinen told EUobserver on Thursday that there is no position yet. The EPP will discuss the issue on 8 March to find out if it can reach a position, and if so what that should be.

He noted that the tobacco agreements were not as important anymore because of new legislation, “but there may still be some value” in them. Pakarinen said that the vote, initially scheduled for 8 March, was postponed by a day.

A spokesman for the ECR, the third largest parliamentary group, said the bloc wanted to “open negotiations but to reserve judgement on any final text”.

Nerudia and Broughton unveil TPD partnership

http://www.tobaccojournal.com/Nerudia_and_Broughton_unveil_TPD_partnership.53497.0.html

Nerudia, which develops nicotine products, and Broughton Laboratories announced a strategic partnership to help e-cigarette companies comply with European regulation of their previously unregulated market.

Vaping products will be regulated in the EU from 20 May, when requirements of the revised Tobacco Products Directive (TPD) take effect. “The analytical capabilities and expertise of Broughton Laboratories are a perfect fit with Nerudia’s regulatory knowledge and our own services,” said Peter Beckett, compliance officer at Nerudia.

E-cigarette tax sets scene for EU lobbying war

https://euobserver.com/science/132510

EU countries are preparing to tax e-cigarettes under the same regime as normal cigarettes, in a move likely to increase prices and to prompt a fight by lobbyists in Brussels.

Last Friday (26 February), member states’ ambassadors agreed to take the first step by asking the European Commission to draft an “appropriate legislative proposal” in 2017.

The project is to be endorsed without further discussion when the bloc’s finance ministers meet on 8 March.

The ministers’ draft conclusions said that e-cigarettes, as well as other “novel” products, could cause “inconsistencies and legal uncertainty” in the single market if they stayed exempt from excise tax.

They also said excise duties or some “other specifically designed tax” on novel tobacco items, which use steam instead of smoke to put nicotine into people’s lungs, could help meet “public health objectives”.

They added that work on the new tax regime should be “intensified” if “the market share of such products show a tendency to increase”.

Prices ‘will rise’

Global e-cigarette sales were about €7.5 billion last year. But analysts forecast they will grow to €46 billion by 2025 or 2030.

Under existing rules, all EU countries must impose an excise tax of at least 57 percent on tobacco products, but most impose only VAT on e-cigarettes at a level of about 20 percent.

In the UK the excise and VAT burden sees the state collect £6.17 every time someone pays the recommended retail price of £7.98 for a pack of 20 premium-brand cigarettes.

The excise income alone is worth €15.5 billion a year.

One EU official said on Monday (29 February) it was “self-evident” that the price of e-cigarettes would go up if the commission went ahead. A second official said it was “too early to say what effect the review” of excise rules might have on prices.

The ministers’ draft conclusions noted that the commission was not obliged to go ahead. But the draft text said EU states would want “reasons” if it did not act.

With several EU capitals still struggling to balance the books, the commission in a report in December also said e-cigarette taxes could have “significant long term budgetary implications” for national treasuries.

Lobbying war

One of the EU officials said the next steps would be “to undertake studies, carry out impact assessments, [and] a public consultation”, setting the stage for a new lobbying war in Brussels.

The last time the EU regulated e-cigarettes, in 2014, big tobacco firms led by Philip Morris International (PMI) tried to dilute the new restrictions on grounds that e-cigarettes help people to quit smoking.

They did it because they were buying up e-cigarette makers to protect their profits.

E-cigarette firms joined them in what Olivier Hoedeman, from Corporate Europe Observatory (CEO), a Brussels-based pro-transparency NGO, called an “angry” campaign with “very strong emotions”.

One MEP at the time got an email saying she would be “finished” if she obstructed e-cigarettes.

EUobserver received emails saying it would be responsible for smokers’ deaths if it published stories giving credence to claims that e-cigarettes are bad for your health.

On the other side, pharmaceutical giants such as GlaxoSmithKline lobbied for tougher EU rules on the grounds that e-cigarettes encouraged young people to start smoking.

They did it because they make nicotine gums and patches, which compete with e-cigarettes for people trying to give up. But gums and patches are regulated under more exacting EU medical product standards.

They were joined by companies such as Trierenberg-Gruppe, the world’s top producer of cigarette papers.

More research needed

Public health advocates such as Cancer Research UK and the European Heart Network are concerned that the corporate lobbyists are ignoring science.

Most health NGOs do not have a position on e-cigarettes because they are too new for conclusive research on long-term benefits and risks.

The European Network for Smoking and Tobacco Prevention, a Brussels-based group, is calling for tougher EU rules.

But its spokesman, Dominick Nguyen, told EUobserver: “This is not about being for or against e-cigarettes, but [about] encouraging research and provision of evidence on e-cigarettes in order to make the right informed decisions.”

Commenting on the “public health” aspect of the excise tax project, CEO’s Hoedeman said: “It would be quite awkward to put e-cigarettes in the same category [as normal cigarettes] if the science isn’t there yet”.

PMI was not available for comment on Monday. GlaxoSmithKline declined to comment.

According to their public declarations, PMI spent up to €1.5 million lobbying EU officials in 2014. GlaxoSmithKline spent up to €2 million.

MEPs split on tobacco deal with PMI

https://euobserver.com/economic/132455

Several members of the European Parliament proposed to EU commissioner Kristalina Georgieva on Thursday (25 February) that there should be an extension of the 12-year tobacco agreement with Philip Morris International (PMI) when it expires in July, while others called on her to let the deal lapse.

“Going back in history, the parliament was very supportive of signing the agreement for a reason, because at that time we had nothing,” Georgieva told MEPs at a plenary session.

“Now the parliament is not so supportive, there are diverging views. Why? Because we have better tools to fight illegal smuggling. But we don’t quite have them just yet.”

The EU and member states signed an agreement with PMI in 2004, which made them partners in the fight against cigarette smuggling and counterfeiting, and included the tobacco multinational transferring around €1 billion over a 12-year period.

Since then, the EU has also signed similar agreements with the three other major tobacco firms, but the PMI one is the first to expire, on 9 July.

But the EU has also adopted a tobacco products directive that covers many aspect of the agreement, and it has also signed up to a World Health Organisation treaty that discourages cooperation with the tobacco industry.

“We have new tools today. The world has changed,” the Bulgarian commissioner said.

However, it will still take three years before the directive is in force, and an estimated six years before the WHO treaty is in place.

“Now the question is whether or not between today and the time when we have the directive in place – 2019 – or the time when we have the protocol enacted in 2022 – we still need a legally binding instrument to fight illegal trade,” she said.

Bridging deal

Some MEPs advocated for a bridging deal, while others said that the agreement should not be renewed.

“Nobody is saying the existing agreements are perfect, in fact they are far from perfect,” said centre-left British MEP Derek Vaughan. But he advocated for an extension “at least as interim measure before the WHO protocol is put in place”, adding that the new deal should be more transparent.

Dutch MEP Dennis de Jong said his group, the far left GUE, is against a renewal.

“The most important argument is that WHO rules require any appearance of a conflict of interest should be avoided. We should not become dependent on money that has blood sticking to it,” said De Jong.

Divided house

While many MEPs were critical of the commission, there was no clear agreement on the deal – even members of the same group were expressing different views.

Georgieva said the commission would “take this debate into account so we can make an informed decision in the near future, in the next weeks”.

But with the house divided and no clear majority either way, the commission will have little difficulty to pursue its own desired path and to point to the “divergence” in opinions in parliament.

The MEPs will vote on a non-binding text about the PMI agreement in the second week of March during their session in Strasbourg, which should show a clearer picture of the opinion of the parliamentarians.

But Georgieva did not answer the question from one MEP if the commission would await the results of the resolution before making up its mind.

When this website put the same question to the European Commission, a spokesperson only referred back to what Georgieva had (not) said.

The long-awaited assessment

The debate in Brussels took place a day after the commission published its long-awaited “technical assessment” of the PMI deal. The document said that, although there was no causal relation that could be proved, the evidence suggested the PMI deal had helped to reduce cigarette smuggling.

It questioned whether the agreement was still relevant today, but noted that it is up to the college of commissioners to decide whether or not it should be renewed. However, it contained few solid arguments for the commission to base such a renewal on.

“I’m sorry, but I do not believe that there are sufficient elements [in the assessment] to renew the existing agreement,” said Green Belgian MEP Bart Staes. His colleague from the centre-right group, Graessle, however said she “could use the same arguments and reach another conclusion”.

In any case, most MEPs agreed they have had to wait far too long for the 31-page report, for which some MEPs have been asking since 2014.

“When the commission ignores the parliament’s request for over two years and turns up [with the report] just before the debate, that is just an example of how real power lies with the commission rather than with the parliament,” said the British eurosceptic MEP Jonathan Arnott, of the UK Independence Party.

“A student could have done this work in less than six months, whereas the commission took 18 months,” said French Green MEP Jose Bove.

But according to Georgieva, it took so long because of the nature of the research. Trying to clarify the causal relation a single agreement had on an illicit activity such as cigarette smuggling is a methodological nightmare.

“There have been very fair comments made that it has taken the Commission time to complete the assessment. Just listening to us in this chamber, the divergence of views, the difficulty of questions that are being asked, this is why it has taken us so much time,” said Georgieva.

Incidentally, many of the points in the assessment, have been made by previous publications, including in EUobserver’s reporting.

Anti-Contraband and Anti-Counterfeit Agreement

Download (PDF, 2.22MB)